Instrumentation Laboratory (IL; Bedford, Massachusetts) said it has received FDA clearance for the first, rapid point-of-care, lab-quality blood test for measuring total bilirubin (tBili) in newborns. Bilirubin, a toxin, can, in high amounts, lead to irreversible brain injury in neonates, the company noted. (Medical Device Daily) Read More
